4
Changes in Ownership
KIORA PHARMACEUTICALS INC Filed Acc 0001104659-21-011844
Options or other derivatives
- Acting CEO acquired 30,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Obermayr Franz Acting CEO | 2021-02-01 | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | D: show line 1 in the form |
Loading xslF345X03/tm215262-2_4seq1.xml…